AI Capex Panic Sinks Nasdaq: AMZN, INTC & RDDT Q3 Analysis

Nasdaq futures plunge 2.4% in October 2026 as AI capex fears trigger a megacap selloff. AMZN drops 7% on -$34.8B FCF, while INTC and RDDT face structural headwinds.

The Pre-Market AI Unwind and Macro Backdrop A second consecutive AI-capex unwind is hitting the tape in late October 2026, transitioning from a sentiment wobble into an earnings-driven rout. Nasdaq futures are pointing sharply lower, down -2.39%, while Dow futures remain essentially flat (-0.02%). This represents the widest growth-to-value divergence in recent weeks, driven by a megacap tech de-rating rather than a broad market liquidation. The macroeconomic backdrop is compounding the pressure on long-duration AI investments. Core PCE for September re-accelerated to 3.1% y/y, and Q3 advance GDP printed at a robust +3.4% annualized. With the Federal Reserve holding rates and the market anticipating a potential rate hike in December, the environment is increasingly hostile to capital-intensive tech narratives. Market platform models reflect this uncertainty. The 7H MLC Index currently reads 5/10 ( Neutral ), with the SPY showing a 57% probability of an upward move, indicating a weak directional signal and low confidence in a broad market rally . Amazon (AMZN): Record AWS Growth Overshadowed by Capex Amazon delivered one of its strongest AWS demand prints in years, yet the stock sold off roughly 7.3% in after-hours trading to $225.99. The market debate has officially shifted from whether AI demand exists to whether Amazon can convert that demand into cash returns without eroding its return on invested capital . Operationally, Q3 2026 was exceptional: Revenue : $201.94B, up 12% y/y. Operating Income : $28.08B (+61% y/y), producing a company-record 13.9% operating margin . AWS Revenue: $46.0B, up 39.3% y/y, marking the sixth consecutive quarter of acceleration. AWS Backlog : Expanded to $578B. Despite these metrics, the stock fell due to severe capital intensity concerns. Q3 free cash flow (FCF) was deeply negative at -$34.84B, overwhelmed by $77.26B in quarterly capex (roughly 38% of revenue). With full-year 2026 cash capex guided to approximately $220B and management signaling meaningfully higher spend in 2027, the bear case centers on delayed cash conversion . Investment Stance: We maintain a Moderate Conviction BUY with a base-case target of $240. The long-term AWS narrative remains compelling, but near-term cash flow strain and rising debt ($271.95B) will likely cap multiple expansion until FCF inflects positively. Intel (INTC): Margin Reset Overrides the AI Promise Intel's Q3 2026 release serves as a case study in strong backward-looking results being overwhelmed by a materially weaker forward view. Shares plunged over 25% in pre-market trading to $68.88 following a disastrous Q4 guidance update. While Q3 revenue of $16.5B beat estimates and the Data Center & AI (DCAI) segment surged 78% y/y to $7.3B, the forward outlook invalidated the margin-recovery thesis: Q4 Revenue Guidance: $15.0B–$16.0B, missing the $17.1B consensus by roughly $2B. Q4 Gross Margin : Guided to a dismal 38.0% ( non-GAAP ), a 610-basis-point sequential contraction. Client Computing (CCPG): Guided to decline more than 20% sequentially as PC demand rolls over into 2027. Crucially, Intel's CFO signaled that 2027 free cash flow is likely to be negative. The company is spending aggressively on capacity and process development, but fixed-cost underabsorption and client weakness are dragging down consolidated profitability. Investment Stance: Downgraded to REDUCE with a target of $65. Intel remains an asset-heavy turnaround story. Until external foundry revenue scales meaningfully beyond the current $411M and FCF turns positive, the execution risk is too high. Reddit (RDDT): Distribution Shock from AI Search Reddit reported operationally excellent Q3 results, but shares tumbled 18.27% after-hours to $106.00 due to a forward-looking reset around traffic acquisition and AI-driven search behavior. Financial highlights were strong: Revenue: $894.96M (+53% y/y). GAAP Operating Margin: 29.2%. Free Cash Flow: $362.57M (+98% y/y). The bearish trigger was management's explicit warning regarding user discovery. Search-referral traffic declined meaningfully in Q3 as Google and AI answer engines sent fewer users to the platform. Management warned that if current trends continue, total DAUqs ( Daily Active Unique users ) could fall by a low-double-digit percentage in Q4 from the current base of 130 million. Investment Stance: Upgraded to Speculative Buy with a lowered target of $133. This upgrade is driven entirely by the severe price dislocation rather than fundamental improvement. At $106, the stock is pricing in the uncertain traffic transition, offering roughly 25% upside to the base case, provided the 29.4% trailing operating margin proves durable. The Great Rotation: Healthcare and Value Catch the Bid As capital flees the AI infrastructure phase, it is rotating hard into earnings-justified defensive sectors . Healthcare and energy are the explicit beneficiaries of this pre-market shift: Merck (MRK): Up +1.95% after reporting Q3 sales of $18.1B (+5%), driven by Keytruda ($8.6B) and Winrevair ($694M). AbbVie (ABBV) & AstraZeneca (AZN): Catching strong bids, up +2.42% and +4.51% respectively, offering visible, non-AI-capex growth. Chevron (CVX): Up +1.91% following strong earnings, adding an energy leg to the value rotation . Investors should monitor breadth closely. A flat Dow against a plunging Nasdaq indicates a healthy rotation rather than a 2022-style liquidation. However, chasing defensive gaps in a single session carries its own risks. Disclaimer: This content is generated by AI. While we strive to ensure accuracy, please use this information for educational purposes only.